IE52877B1 - Phenethanolamine derivatives, their preparation and their application in therapeutics - Google Patents

Phenethanolamine derivatives, their preparation and their application in therapeutics

Info

Publication number
IE52877B1
IE52877B1 IE869/82A IE86982A IE52877B1 IE 52877 B1 IE52877 B1 IE 52877B1 IE 869/82 A IE869/82 A IE 869/82A IE 86982 A IE86982 A IE 86982A IE 52877 B1 IE52877 B1 IE 52877B1
Authority
IE
Ireland
Prior art keywords
formula
phenethanolamine
pharmaceutically acceptable
acid addition
acceptable acid
Prior art date
Application number
IE869/82A
Other languages
English (en)
Other versions
IE820869L (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IE820869L publication Critical patent/IE820869L/xx
Publication of IE52877B1 publication Critical patent/IE52877B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Artificial Filaments (AREA)
  • Lubricants (AREA)
IE869/82A 1981-04-14 1982-04-14 Phenethanolamine derivatives, their preparation and their application in therapeutics IE52877B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8107445A FR2503705A1 (fr) 1981-04-14 1981-04-14 Derives de phenethanolamine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IE820869L IE820869L (en) 1982-10-14
IE52877B1 true IE52877B1 (en) 1988-03-30

Family

ID=9257367

Family Applications (1)

Application Number Title Priority Date Filing Date
IE869/82A IE52877B1 (en) 1981-04-14 1982-04-14 Phenethanolamine derivatives, their preparation and their application in therapeutics

Country Status (20)

Country Link
US (1) US4430334A (en, 2012)
EP (1) EP0063084B1 (en, 2012)
JP (1) JPS57179160A (en, 2012)
AT (1) ATE9330T1 (en, 2012)
AU (1) AU545216B2 (en, 2012)
CA (1) CA1185604A (en, 2012)
DE (1) DE3260703D1 (en, 2012)
DK (1) DK154979C (en, 2012)
ES (1) ES511365A0 (en, 2012)
FI (1) FI821288L (en, 2012)
FR (1) FR2503705A1 (en, 2012)
GR (1) GR75543B (en, 2012)
HU (1) HU186492B (en, 2012)
IE (1) IE52877B1 (en, 2012)
IL (1) IL65493A (en, 2012)
MX (1) MX155561A (en, 2012)
NO (1) NO821192L (en, 2012)
NZ (1) NZ200275A (en, 2012)
PT (1) PT74744B (en, 2012)
ZA (1) ZA822489B (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
US4912117A (en) * 1985-07-02 1990-03-27 Merrell Dow Pharmaceuticals Inc. Novel chemical compounds
US4783471A (en) * 1985-07-02 1988-11-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine methanol derivatives and the uses thereof
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
FR2678269B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique.
FR2696741B1 (fr) * 1992-10-12 1994-11-25 Synthelabo Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique.
US20070048577A1 (en) * 2005-08-30 2007-03-01 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Naval Re Scalable microbial fuel cell with fluidic and stacking capabilities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (en, 2012) * 1966-09-27 1968-01-22
DE1618010A1 (de) * 1967-06-15 1970-11-05 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Aminoketonen
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
AT354187B (de) * 1976-11-22 1979-12-27 Hoffmann La Roche Fungizides mittel

Also Published As

Publication number Publication date
PT74744B (fr) 1985-01-08
AU545216B2 (en) 1985-07-04
FR2503705A1 (fr) 1982-10-15
JPS57179160A (en) 1982-11-04
PT74744A (fr) 1982-05-01
DE3260703D1 (en) 1984-10-18
FR2503705B1 (en, 2012) 1983-11-04
FI821288A0 (fi) 1982-04-13
JPS6124388B2 (en, 2012) 1986-06-10
DK165282A (da) 1982-10-15
MX155561A (es) 1988-03-25
GR75543B (en, 2012) 1984-07-27
FI821288A7 (fi) 1982-10-15
ATE9330T1 (de) 1984-09-15
EP0063084B1 (fr) 1984-09-12
US4430334A (en) 1984-02-07
CA1185604A (en) 1985-04-16
DK154979C (da) 1989-07-10
ZA822489B (en) 1983-02-23
ES8304548A1 (es) 1983-03-01
DK154979B (da) 1989-01-16
IE820869L (en) 1982-10-14
FI821288L (fi) 1982-10-15
IL65493A0 (en) 1982-07-30
HU186492B (en) 1985-08-28
EP0063084A1 (fr) 1982-10-20
ES511365A0 (es) 1983-03-01
NO821192L (no) 1982-10-15
IL65493A (en) 1985-03-31
NZ200275A (en) 1984-07-06
AU8255582A (en) 1982-10-21

Similar Documents

Publication Publication Date Title
US3354174A (en) 1-and 2-benzimidazolyl-lower-alkylamidoximes, amidines-, and guanidines
EP0087810B1 (en) Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient
US4730042A (en) Compounds 1 or 3-hydroxy-4-benzyl-6-methyl-7-(4-isopropylamino-butoxy)-1,3-dihydro[3,4-C]pyridine and 2-methyl-3-(4-isopropyl-aminobutoxy)-4-(1'-morphilinomethyl)-5-hydroxymethyl-6-benzyl pyridine, useful for treating cardiac arrhythmias
US4717563A (en) 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs
US4575508A (en) 2-Substituted 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-β-carbolines, and their use as antiarrhythmic agents
US4430334A (en) Phenethanolamine derivatives for use against cerebrovascular disease
US4877794A (en) 2-Alkoxy-n-(1-azabicyclo(2.2.2)oct-3-yl) benzamide and thiobenzamide compositions and the use thereof to treat schizophrenia
US4940789A (en) 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents
US3515725A (en) 2,3a-diazahydrindanone and 3h-pyrido-(1,2-c)pyrimidin-3-one derivatives
JPS6365664B2 (en, 2012)
EP0105458B1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
US2914532A (en) Lower alkyl 4-phenyl-1-(3-phenylpropyl) piperidine-4-carboxylates and their preparation
US4143143A (en) Substituted imidazo[5,1-a]isoquinolines
US4992457A (en) Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
JPH02503912A (ja) 薬理学的活性のあるコリン作動性組成物と、その製造方法と、その治療への応用
IE59173B1 (en) Imidazo[1,2-a]quinoline derivatives, their preparation and their application in therapy
US5508401A (en) Substituted dibenzo[a,d]cycloheptene NMDA antagonists
CA1162544A (en) Naphthyridine derivatives
US3864359A (en) 5-amino-3-ethyl-1-phenyl-4-pyrazolecarboxamides and method of preparation thereof
US4503058A (en) Therapeutically useful 3,7a-diazacyclohepta[j,k]fluorene derivatives
IE902844A1 (en) New oxazolopyridine derivatives, process for preparing them¹and pharmaceutical compositions containing them
PL116771B1 (en) Process for preparing novel derivatives of 1,3-benzoxazynodi-2,4-one
US3553267A (en) 3-dimethylamino-1,2,3,4-tetrahydrofluorene
US4588526A (en) Bronchodilatory azepino(1,2-A)pyrimidine derivatives and acid addition salts thereof and bronchodilating pharmaceutical compositions containing same
US4183933A (en) Diarylbutyl octahydropyrazinopyrimidinones and methods of medical treatment using them